Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiffany Richards

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Canadian Journal of Diabetes|December 3, 2019
In-Hospital Feeding Practices of Infants Born to Mothers With Gestational Diabetes Mellitus or Type 2 Diabetes Mellitus: Evaluating Policy Implementation EffectivenessErin Carmody, Tiffany Richards, Kathryn Hayward, et al.
Development (Cambridge, England)|June 9, 2009
Cell volume regulation is initiated in mouse oocytes after ovulationAlina P Tartia, Nirmala Rudraraju, Tiffany Richards, et al.
Palliative & Supportive Care|June 25, 2014
Clinical perspective: Linking psychosocial care to the disease continuum in patients with multiple myelomaJames Zabora, Joanne Buzaglo, Vicki Kennedy, et al.
Clinical Journal of Oncology Nursing|September 26, 2017
Distress, Fatigue, and Sexuality: Understanding and Treating Concerns and Symptoms in Patients With Multiple Myeloma 
Donna Catamero, Kimberly Noonan, Tiffany Richards, et al.
JBI Evidence Synthesis|June 21, 2021
Food security in African Canadian communities: a scoping reviewKeisha Jefferies, Tiffany Richards, Nicole Blinn, et al.
Current Medical Research and Opinion|August 23, 2024
Real-world experience with clinical management of talquetamab in relapsed/refractory multiple myeloma: a qualitative study of US healthcare providersCarolina Schinke, Binod Dhakal, Sandra Mazzoni, et al.
Blood Cancer Journal|June 25, 2025
Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy ConsortiumDanai Dima, Mariola A Vazquez-Martinez, James A Davis, et al.
Blood Cancer Journal|May 9, 2025
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy ConsortiumOren Pasvolsky, Danai Dima, Lei Feng, et al.
Blood Advances|July 2, 2026
Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell LeukemiaMahmoud R Gaballa, Kelley Julian, Aimaz Afrough, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Canadian Journal of Diabetes|December 3, 2019
In-Hospital Feeding Practices of Infants Born to Mothers With Gestational Diabetes Mellitus or Type 2 Diabetes Mellitus: Evaluating Policy Implementation EffectivenessErin Carmody, Tiffany Richards, Kathryn Hayward, et al.
Development (Cambridge, England)|June 9, 2009
Cell volume regulation is initiated in mouse oocytes after ovulationAlina P Tartia, Nirmala Rudraraju, Tiffany Richards, et al.
Palliative & Supportive Care|June 25, 2014
Clinical perspective: Linking psychosocial care to the disease continuum in patients with multiple myelomaJames Zabora, Joanne Buzaglo, Vicki Kennedy, et al.
Clinical Journal of Oncology Nursing|September 26, 2017
Distress, Fatigue, and Sexuality: Understanding and Treating Concerns and Symptoms in Patients With Multiple Myeloma 
Donna Catamero, Kimberly Noonan, Tiffany Richards, et al.
JBI Evidence Synthesis|June 21, 2021
Food security in African Canadian communities: a scoping reviewKeisha Jefferies, Tiffany Richards, Nicole Blinn, et al.
Current Medical Research and Opinion|August 23, 2024
Real-world experience with clinical management of talquetamab in relapsed/refractory multiple myeloma: a qualitative study of US healthcare providersCarolina Schinke, Binod Dhakal, Sandra Mazzoni, et al.
Blood Cancer Journal|June 25, 2025
Outcomes of teclistamab in patients with relapsed/refractory multiple myeloma with prior exposure to BCMA-directed therapy: a multicenter study from the U.S. Multiple Myeloma Immunotherapy ConsortiumDanai Dima, Mariola A Vazquez-Martinez, James A Davis, et al.
Blood Cancer Journal|May 9, 2025
Outcomes of elderly patients with relapsed refractory multiple myeloma (RRMM) treated with teclistamab: a multicenter study from the U.S. Multiple Myeloma Immunotherapy ConsortiumOren Pasvolsky, Danai Dima, Lei Feng, et al.
Blood Advances|July 2, 2026
Real-World Outcomes with BCMA- and GPRC5D-Targeting Bispecific Antibodies in Plasma Cell LeukemiaMahmoud R Gaballa, Kelley Julian, Aimaz Afrough, et al.
Pageof 2